Macular Edema Market Global Pipeline Review Research for H2 2016

Wednesday, February 1, 2017 Research News
Email Print This Page Comment bookmark
Font : A-A+

PUNE, India, February 1, 2017 /PRNewswire/ -- adds "Macular Edema - Pipeline Review, H2 2016"

to its store providing comprehensive information on the therapeutics under development for Macular Edema (Respiratory), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule
type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Browse 26 market data tables and 12 figures, spread across 63 pages is available at .

Companies discussed in this Macular Edema Pipeline Review, H2 2016 report include ActiveSite Pharmaceuticals, Inc., Ampio Pharmaceuticals, Inc., Chong Kun Dang Pharmaceutical Corp., Clearside BioMedical, Inc., Coherus BioSciences, Inc., Mabion SA, Pfizer Inc., Precision Ocular Ltd, Promedior, Inc., Taiwan Liposome Company, Ltd., Valeant Pharmaceuticals International, Inc. and Xbrane Biopharma AB. Drug Profiles mentioned in this research report are (aflibercept + triamcinolone acetonide), ACX-107, ASPPDC-020, BLO-021, celecoxib, danazol, dexamethasone sodium phosphate SR, HO-10, PRM-167 and ranibizumab biosimilar.

The Macular Edema (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Macular Edema and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Preclinical, Discovery and Unknown stages are 2, 9, 1 and 1 respectively. Macular Edema.

Order a Purchase Copy of this Report @

Scope of this report: The report provides a snapshot of the global therapeutic landscape of Macular Edema and reviews pipeline therapeutics for Macular Edema by companies and universities/research institutes based on information derived from company and industry-specific sources and key players involved Macular Edema therapeutics and enlists all their major and minor projects. The research covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages. The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities and assesses Macular Edema therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report summarizes all the dormant and discontinued pipeline projects with latest news related to pipeline therapeutics for Macular Edema.

Another newly published market research report titled on Diabetic Retinopathy - Pipeline Review, H2 2016 ( provides comprehensive information on the therapeutic development for Diabetic Retinopathy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. Companies Involved in Therapeutics Development are Acucela Inc., Aerie Pharmaceuticals, Inc., Aerpio Therapeutics, Inc., Amakem NV, Antisense Therapeutics Limited, Araim Pharmaceuticals, Inc., BCN Peptides, S.A., Biomar Microbial Technologies, Charlesson LLC., Coherus BioSciences and more.

Explore more reports on Pharmaceuticals Market

About Us: is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Contact: Ritesh Tiwari UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune - 411013 Maharashtra, India. Tel: +1-888-391-5441

SOURCE ReportsnReports


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store